MARKET

BNTX

BNTX

BIONTECH
NASDAQ
94.84
+0.32
+0.34%
Opening 10:23 12/29 EST
OPEN
94.28
PREV CLOSE
94.52
HIGH
95.15
LOW
94.00
VOLUME
102.85K
TURNOVER
--
52 WEEK HIGH
129.27
52 WEEK LOW
81.20
MARKET CAP
22.80B
P/E (TTM)
-34.2618
1D
5D
1M
3M
1Y
5Y
1D
Genmab scraps development of experimental cancer therapy
Reuters · 2h ago
Weekly Report: what happened at BNTX last week (1222-1226)?
Weekly Report · 7h ago
Genmab–BioNTech Cancer Antibody Trial Ends Early: What Investors Need to Know
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Disc Medicine (IRON) and Ascendis Pharma (ASND)
TipRanks · 12/22 14:00
Weekly Report: what happened at BNTX last week (1215-1219)?
Weekly Report · 12/22 09:35
New Pumitamig Kidney Cancer Trial Adds Long-Term Optionality for Bristol-Myers Squibb and BioNTech
TipRanks · 12/19 16:30
BioNTech Completes CureVac Acquisition to Bolster mRNA Leadership
TipRanks · 12/18 21:48
BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206
TipRanks · 12/18 16:32
More
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Webull offers BioNTech SE - ADR stock information, including NASDAQ: BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.